Trial Details
AuthorisedBasic Information
| Clinical ID | c5072 |
|---|---|
| Identifier | EUCTR2019-000668-27-ES |
| Trial Title | Pilot Project for the Treatment of Perianal Disease through the Local Injection of Remsima Guided by Ultrasound. Number of cases. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Perianal disease (PD): alteration associated with inflammatory bowel disease (IBD) that includes fissures, ulcers, fistulas or abscesses, and is one of the most difficult aspects of treating IBD. Both by direct affectation of the sphincters and by the rep |
| Interventions | Trade Name: Remsima Product Name: Remsima Product Code: CT-P13 Pharmaceutical Form: Powder for concentrate for solution for infusion INN or Proposed INN: INFLI |
Participant Information
| Sponsor | Marta Maia BoscWatts |
|---|---|
| City | NULL |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |